Overview
Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens
Status:
Completed
Completed
Trial end date:
2009-05-01
2009-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
AD is a disease found in children; the focus of the study is the mechanisms associated in children with AD induced by food allergies. This study will be a randomized, double-blind, placebo-controlled, parallel group trial conducted in participants diagnosed with atopic dermatitis and food allergies. The study duration for participants will be approximately 9 weeks. A total of 20 participants will be recruited for the entire study. Each arm will consist of 10 participants.The study will enroll 20 children, male or female, 1 - 8 years of age with atopic dermatitis (AD) associated with food allergens, previously documented by skin or RAST test, before enrollment. Atopic dermatitis and gastrointestinal (GI) symptoms will be scored and followed throughout the study.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
1st Allergy & Clinical Research CenterTreatments:
Montelukast
Criteria
Inclusion Criteria:1. Mild to moderate atopic dermatitis involving greater than or equal to 5% of body
surface
2. Total severity score of 2 or greater for any 3 of the 4 signs and symptoms calculated
by study doctor (erythema, papulation, or lichenification)
3. Positive skin or (radioallergosorbent) RAST tests by ImmunoCap to food or
environmental allergens
4. GI symptoms total score of 2 by caregiver on GSRS scale revised for pediatrics
Exclusion Criteria:
1. Participants with intolerance or allergy to montelukast.
2. History of anaphylaxis requiring hospitalization.
3. No underlying renal or liver disease.
4. Participants with a diagnosis of severe asthma.
5. Participants diagnosed with primary immune deficiency.
6. Participants using sublingual immunotherapy.
7. Immunotherapy must be a maintenance dose for a minimum of 30 days.
8. If on gastrointestinal medication, 30 day stable dose before visit 1 and maintained
throughout the study.